Find out what your plan would pay.

Ask your plan about the named product and use

• Is this product on my plan’s list of covered medicines?
• Does coverage depend on the condition being treated?
• Does the plan want an approval request before paying?
• Please split my payment into the appointment, the tests and the product.
• If I pay cash, will any of that count toward my plan’s spending limits?

Translate the payment terms

A formulary is an insurance plan’s medicine list; prior authorization is its approval step before payment.

Have the exact product name and the proposed reason for treatment ready when you call. Ask for the answer in writing, with any conditions attached.

Medicare may pay when a medicine treats an accepted condition other than weight loss, such as diabetes. That was the position checked September 26, 2026.

Medicare is the federal health coverage program. Even then, the plan’s own payment rules still apply.

A limited Medicare program has separate terms

GLP-1 is a hormone tied to blood sugar and appetite; medicines in this group mimic its action.

Medicare calls its temporary test program for selected medicines the GLP-1 Bridge.

In the Bridge terms at September 26, 2026, eligible people paid a $50 monthly copay, meaning their share of the medicine bill. Those terms span July 1, 2026 to a scheduled finish of December 31, 2027.

Part D is Medicare’s usual prescription-drug coverage. The Bridge pays separately from it. Your $50 Bridge payment does not reduce the amount you must pay under Part D before that plan starts paying. Your plan also leaves it out when adding up your payments toward the yearly Part D limit.

Have the prescriber and your plan confirm whether the Bridge or your usual drug coverage applies before relying on the advertised price.

Read Medicare’s Bridge eligibility and product terms

Return to the full-cost sheet